Clinical Trial Update: Evaluation of the Medidux™ Digital Health Application in Patients With HER2-positive Breast Cancer. [NA]

View source ↗

Summary

The clinical trial evaluating the Medidux digital health application for HER2-positive breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Medidux

Snippet

Sponsor: Palleos Healthcare GmbH | Conditions: Breast Cancer | NA | Status: TERMINATED